Savara (SVRA) Preferred Stock Liabilities (2014 - 2016)

Savara (SVRA) reported Preferred Stock Liabilities of $43.9 million for Q4 2016, up 2.04% year-over-year from $43.0 million in Q1 2016, and up 2.04% quarter-over-quarter from $43.0 million in Q4 2015.

Savara (SVRA) Preferred Stock Liabilities (2014 - 2016) Analysis & Trends

Savara (SVRA) has 3 years of Preferred Stock Liabilities data on file, last reported at $43.9 million in Q4 2016.

  • Preferred Stock Liabilities for Q4 2016 came in at $43.9 million, up 2.04% year-over-year; the trailing twelve-month figure through Dec 2016 was $43.9 million (up 2.04% YoY), and the FY2016 annual result was $43.9 million, up 2.04% from the prior year.
  • Preferred Stock Liabilities improved to $43.9 million in Q4 2016 per SVRA's latest filing, from $43.0 million in the prior quarter.
  • Over five years, Preferred Stock Liabilities peaked at $43.9 million in Q4 2016 and troughed at $20.3 million in Q4 2014.
  • A 3-year average of $35.7 million and a median of $43.0 million in 2015 frame the typical range for Preferred Stock Liabilities.
  • The sharpest annual moves came in 2015 and 2016: Preferred Stock Liabilities soared 112.05% in 2015, then gained 2.04% in 2016.
  • A 3-year view of Preferred Stock Liabilities shows it stood at $20.3 million in 2014, then jumped by 112.05% to $43.0 million in 2015, then rose by 2.04% to $43.9 million in 2016.
  • Business Quant data shows SVRA's Preferred Stock Liabilities at $43.9 million in Q4 2016, $43.0 million in Q4 2015, and $20.3 million in Q4 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Savara 1.39 Bn 1.39 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2016 43.86 Mn
Dec 31, 2015 42.99 Mn
Dec 31, 2014 20.27 Mn